Carna Biosciences, Inc.
TSE:4572.T
304 (JPY) • At close November 5, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Carna Biosciences, Inc. |
Symbool | 4572.T |
Munteenheid | JPY |
Prijs | 304 |
Beurswaarde | 5,805,906,304 |
Dividendpercentage | 0% |
52-weken bereik | 285 - 876 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Kohichiro Yoshino Ph.D. |
Website | https://www.carnabio.com |
An error occurred while fetching data.
Over Carna Biosciences, Inc.
Carna Biosciences, Inc., a clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan. Its products include kinase proteins, substrates, kinase protein assay kits, and stable cell lines, as well as biotinylated kinases to use in the study of kinase-molecule interactions. The company also offers
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (JPY)
Cijfers zijn in miljoenen (JPY)